Biopsy-Verified Bronchiolitis Obliterans and Other Noninfectious Lung Pathologies after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 3, 2015, Pages 531-538

  Uhlving, Hilde Hylland ^a   Andersen, Claus B ^a   Christensen, Ib Jarle ^b   Gormsen, Magdalena ^a   Pedersen, Karen Damgaard ^a   Buchvald, Frederik ^a   Heilmann, Carsten ^a   Nielsen, Kim Gjerum ^a   Mortensen, Jann ^a   Moser, Claus ^a   Sengeløv, Henrik ^a   Müller, Klaus Gottlob ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bronchiolitis obliterans; Bronchiolitis obliterans syndrome; Chronic graft versus host disease; Hematopoietic stem cell transplantation; Pulmonary function tests; Pulmonary pathology

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION; MALE; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PROGNOSIS; PROGNOSTIC ASSESSMENT; SURVIVAL RATE; ADOLESCENT; ALLOGRAFT; BIOPSY; CHILD; CLINICAL TRIAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; LUNG; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALLOGRAFTS; BIOPSY; BRONCHIOLITIS OBLITERANS; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LUNG; MIDDLE AGED;

EID: 84922777063     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.12.004     Document Type: Article

References (47)

1. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006, 12:31-47.
2. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease. I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2005, 11:945-956.
3. Forslow U., Mattsson J., Gustafsson T., Remberger M. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:1214-1221.
4. Au B.K., Au M.A., Chien J.W. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011, 17:1072-1078.
5. Bergeron A., Godet C., Chevret S., et al. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplant 2013, 48:819-824.
6. Duque-Afonso J., Ihorst G., Wasch R., et al. Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation. Bone Marrow Transplant 2013, 48:1098-1103.
7. Ditschkowski M., Elmaagacli A.H., Koldehoff M., et al. Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight-new perspectives?. Bone Marrow Transplant 2013, 48:1224-1229.
8. Gazourian L., Coronata A.M., Rogers A.J., et al. Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Respir Med 2013, 107:276-283.
9. Santo Tomas L.H., Loberiza F.R., Klein J.P., et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005, 128:153-161.
10. Nakaseko C., Ozawa S., Sakaida E., et al. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. Int J Hematol 2011, 93:375-382.
11. Clark J.G., Crawford S.W., Madtes D.K., Sullivan K.M. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989, 111:368-376.
12. Dudek A.Z., Mahaseth H., DeFor T.E., Weisdorf D.J. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003, 9:657-666.
13. Yoshihara S., Tateishi U., Ando T., et al. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant 2005, 35:1195-1200.
14. Schultz K.R., Green G.J., Wensley D., et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994, 84:3212-3220.
15. Williams K.M., Chien J.W., Gladwin M.T., Pavletic S.Z. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009, 302:306-314.
16. Uhlving H.H., Buchvald F., Heilmann C.J., et al. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplant 2012, 47:1020-1029.
17. Hildebrandt G.C., Fazekas T., Lawitschka A., et al. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011, 46:1283-1295.
18. Gunn M.L., Godwin J.D., Kanne J.P., et al. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. JThorac Imaging 2008, 23:244-250.
19. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
20. MacIntyre N., Crapo R.O., Viegi G., et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26:720-735.
21. Wanger J., Clausen J.L., Coates A., et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005, 26:511-522.
22. Stanojevic S., Wade A., Stocks J., et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008, 177:253-260.
23. Koopman M., Zanen P., Kruitwagen C.L., et al. Reference values for paediatric pulmonary function testing: the Utrecht dataset. Respir Med 2011, 105:15-23.
24. Cotes J.E., Chinn D.J., Quanjer P.H., et al. [Standardization of the measurement of transfer factor (diffusing capacity). Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]. Rev Mal Respir 1994, 11(Suppl. 3):41-52.
25. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. JHeart Lung Transplant 2002, 21:297-310.
26. Verleden G.M., Raghu G., Meyer K.C., et al. Anew classification system for chronic lung allograft dysfunction. JHeart Lung Transplant 2014, 33:127-133.
27. Holbro A., Lehmann T., Girsberger S., et al. Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19:973-980.
28. Song I., Yi C.A., Han J., et al. CT findings of late-onset noninfectious pulmonary complications in patients with pathologically proven graft-versus-host disease after allogeneic stem cell transplant. AJR Am J Roentgenol 2012, 199:581-587.
29. Sargent M.A., Cairns R.A., Murdoch M.J., et al. Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT. AJR Am J Roentgenol 1995, 164:693-696.
30. Jung J.I., Jung W.S., Hahn S.T., et al. Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings. Korean J Radiol 2004, 5:107-113.
31. Chan C.K., Hyland R.H., Hutcheon M.A., et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987, 66:327-340.
32. Holland H.K., Wingard J.R., Beschorner W.E., et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988, 72:621-627.
33. Yousem S.A. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995, 26:668-675.
34. Yokoi T., Hirabayashi N., Ito M., et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group. Virchows Arch 1997, 431:275-282.
35. Trisolini R., Bandini G., Stanzani M., et al. Morphologic changes leading to bronchiolitis obliterans in a patient with delayed non-infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001, 28:1167-1170.
36. Nakamoto-Matsubara R., Nishikii H., Yamada K., et al. Early pathologic findings of bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a proposal from a case. Case Rep Hematol 2012, 2012:957612.
37. Burton C.M., Iversen M., Carlsen J., Andersen C.B. Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies. Transplantation 2008, 86:811-819.
38. Philit F., Wiesendanger T., Archimbaud E., et al. Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995, 8:551-558.
39. Chan A., Allen R. Bronchiolitis obliterans: an update. Curr Opin Pulm Med 2004, 10:133-141.
40. Kongstad T., Buchvald F.F., Green K., et al. Improved air trapping evaluation in chest computed tomography in children with cystic fibrosis using real-time spirometric monitoring and biofeedback. JCyst Fibros 2013, 12:559-566.
41. Galban C.J., Boes J.L., Bule M., et al. Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014, 20:1592-1598.
42. Kuzmina Z., Eder S., Bohm A., et al. Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study. Leukemia 2012, 26:746-756.
43. Vogl U.M., Nagayama K., Bojic M., et al. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Transplantation 2013, 95:623-628.
44. Kuzmina Z., Krenn K., Petkov V., et al. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome. Blood 2013, 121:1886-1895.
45. Nakasone H., Kanda J., Yano S., et al. Acase-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Transplant Int 2013, 26:631-639.
46. Yanagawa N., Sakai F., Kamata N., et al. High-resolution computed tomography features of pulmonary chronic graft-versus-host disease following hematopoietic stem cell transplantation: histopathological correlation. Jpn J Radiol 2011, 29:116-128.
47. Norman B.C., Jacobsohn D.A., Williams K.M., et al. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients. Bone Marrow Transplant 2011, 46:1369-1373.